You certainly don't want to infect anyone with SARS!
It's like someone showing you a dead man and saying "he is survived by an identical twin brother that is wanted for murder."
The new vaccine will likely be a protein that provokes an immune reaction to some essential part of the virus and it will be made by more effective means like genetic modification of eg. a pet microbe or yeast.
No egg as a side dish I guess.
• Live-attenuated vaccines: these use a weakened (or attenuated) form of the germ that causes a disease.
• Inactivated vaccines: these use the killed version of the germ that causes a disease.
• Subunit, recombinant, polysaccharide, and conjugate vaccines: these use specific pieces of the germ — like its protein, sugar, or capsid (a casing around the germ).
• Toxoid vaccines: these use a toxin (harmful product) made by the germ that causes a disease. They create immunity to the parts of the germ that cause a disease instead of the germ itself.
Two notes:
1. SARS-CoV is the 2003 strain, which is generally accepted as being the more severe - yet more difficult to transmit - strain of coronavirus. So in this case (unless I'm misunderstanding), people who caught and survived the more severe SARS-CoV in 2003-2004 are less likely to be as affected by the milder SARS-CoV-2 strain. Worth noting that the population of people infected by SARS-CoV is not all that high, so the value isn't so much that there's a population protected from SARS-CoV-2 as it's that there's enough of a similarity between the two strains that we could learn a few useful things about treating the latter.
2. The model you described, using a milder agent to protect against a severe one, is the original concept behind vaccines, done by Dr. Edward Jenner with Cowpox to protect against Smallpox. https://en.wikipedia.org/wiki/Smallpox_vaccine
Interesting idea. Infect everyone with the “mild” version of SARS to protect against the severe one.